Tranzactioneaza UCB (BE.UCB) - 138.15 EUR (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 137.1000 EUR
Ask 138.3500 EUR
Minim 136.0000 EUR
Maxim 138.6500 EUR
Pret referinta 136.8500
Volum -
Volum ultima zi 1
Max 52 sapt 139.0500 EUR
Min 52 sapt 65.5800 EUR

Descriere companie

Ucb SA (https://www.ucb.com/) is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Informatii companie

Nume

UCB

Buna ziua, sunt TreVi. Spuneti-mi, va rog, cu ce informatii va pot fi de folos.